Turnover Talk: Molecular Testing and Patient Selection in Ovarian Cancer
A brief discussion of homologous recombination deficiency, loss of heterozygosity, and molecular markers in ovarian cancer, and how this can guide therapy.
Category
- Turnover Talks
- Ovary
- Genetics
- Targeted Therapy
Format
- On-Demand
Credits